Life sciences news
-
Possible therapeutic targets identified for ALS and frontotemporal dementia
Wednesday September 14th 2022
Read more
-
ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers
Monday September 12th 2022
Read more
-
Precirix enters into collaboration with Eckert & Ziegler for the development of its 68Ga-based compounds
Monday September 12th 2022
Read more
-
Carroucell raises €1.5 million to introduce breakthrough microcarriers and customizable processes to cell and gene therapy market
Thursday September 8th 2022
Read more
-
New three-year BIMZELX®▼ (bimekizumab) data reinforce long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis
Wednesday September 7th 2022
Read more
-
BioLizard is now an Official Illumina Connected Analytics Implementation Partner
Monday September 5th 2022
Read more
-
flanders.bio has relocated!
Monday September 5th 2022
Read more
-
Nieuwe investering voor HERAN Partners: Aspect Analytics
Monday September 5th 2022
Read more
-
Your news here?
-
Pathomation announces new release of the “My Pathomation” cloud platform for digital pathology
Friday September 2nd 2022
Read more
-
Biocartis initiates commercialization in Europe of SkylineDx’s innovative Merlin™ Assay (CE-IVD) for melanoma patients
Thursday September 1st 2022
Read more
-
reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration
Wednesday August 31st 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator